Actuate Therapeutics Inc (ACTU) vs Quantum BioPharma Ltd. (QNTM)
A side-by-side comparison of Actuate Therapeutics Inc and Quantum BioPharma Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACTU
Actuate Therapeutics Inc
$0.84HealthcareDelayed quote: Oct 6, 2026, 12:52 PM EDT
QNTM
Quantum BioPharma Ltd.
$3.27HealthcareDelayed quote: Oct 6, 2026, 12:49 PM EDT
Total return — ACTU vs QNTM
growth of $100 · dividends reinvested · last 2yACTU -89.8% (-68.1%/yr)QNTM -49.7% (-29.1%/yr)QNTM compounded faster over this window
ACTU QNTM
ACTU vs QNTM: by the numbers
- •QNTM is the larger company ($21M vs $20M market cap).
Metrics side by side
Valuation
| Metric | ACTU | QNTM |
|---|---|---|
| P/B ratio | 20.23 | 2.63 |
Profitability
| Metric | ACTU | QNTM |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -2067.81% | -313.46% |
| ROIC | -1489.99% | -27.14% |
Growth (annualized)
| Metric | ACTU | QNTM |
|---|---|---|
| Total return CAGR (5Y) | N/A | -49.16% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.